REATA PHARMACEUTICALS INC Selling, General and Administrative Expense
REATA PHARMACEUTICALS INC reported Selling, General and Administrative Expense of $45.69 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-08-08
- REATA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2023-06-30 was $45.69M, a 81.72% increase year-over-year.
- REATA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2023-03-31 was $54.88M, a 120.95% increase year-over-year.
- REATA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2022-06-30 was $25.14M.
- REATA PHARMACEUTICALS INC selling, general and administrative expense for the quarter ending 2022-03-31 was $24.84M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month |
|---|---|---|
| 2023-06-30 | $45.69M 10-Q · filed 2023-08-08 | $100.58M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $54.88M 10-Q · filed 2023-05-10 | |
| 2022-06-30 | $25.14M 10-Q · filed 2023-08-08 | $49.98M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $24.84M 10-Q · filed 2023-05-10 |